Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Diabetologia. 2022 Jun;65(6):964-972. doi: 10.1007/s00125-022-05659-9. Epub 2022 Mar 22.
AIMS/HYPOTHESIS: Mortality has declined in people with type 1 diabetes in recent decades. We examined how the pattern of decline differs by country, age and sex, and how mortality trends in type 1 diabetes relate to trends in general population mortality.
We assembled aggregate data on all-cause mortality during the period 2000-2016 in people with type 1 diabetes aged 0-79 years from Australia, Denmark, Latvia, Scotland, Spain (Catalonia) and the USA (Kaiser Permanente Northwest). Data were obtained from administrative sources, health insurance records and registries. All-cause mortality rates in people with type 1 diabetes, and standardised mortality ratios (SMRs) comparing type 1 diabetes with the non-diabetic population, were modelled using Poisson regression, with age and calendar time as quantitative variables, describing the effects using restricted cubic splines with six knots for age and calendar time. Mortality rates were standardised to the age distribution of the aggregate population with type 1 diabetes.
All six data sources showed a decline in age- and sex-standardised all-cause mortality rates in people with type 1 diabetes from 2000 to 2016 (or a subset thereof), with annual changes in mortality rates ranging from -2.1% (95% CI -2.8%, -1.3%) to -5.8% (95% CI -6.5%, -5.1%). All-cause mortality was higher for male individuals and for older individuals, but the rate of decline in mortality was generally unaffected by sex or age. SMR was higher in female individuals than male individuals, and appeared to peak at ages 40-70 years. SMR declined over time in Denmark, Scotland and Spain, while remaining stable in the other three data sources.
CONCLUSIONS/INTERPRETATION: All-cause mortality in people with type 1 diabetes has declined in recent years in most included populations, but improvements in mortality relative to the non-diabetic population are less consistent.
目的/假设:近几十年来,1 型糖尿病患者的死亡率有所下降。我们研究了死亡率的下降模式在不同国家、年龄和性别之间的差异,以及 1 型糖尿病患者的死亡率趋势与普通人群死亡率趋势的关系。
我们汇总了 2000 年至 2016 年期间来自澳大利亚、丹麦、拉脱维亚、苏格兰、西班牙(加泰罗尼亚)和美国(Kaiser Permanente Northwest)的 0-79 岁 1 型糖尿病患者全因死亡率的综合数据。数据来自行政来源、健康保险记录和登记处。使用泊松回归模型对 1 型糖尿病患者的全因死亡率和标准化死亡率比(SMR)进行建模,年龄和日历时间作为定量变量,使用年龄和日历时间的六个结限制立方样条来描述效果。死亡率按 1 型糖尿病患者的年龄分布进行标准化。
所有六个数据源均显示 2000 年至 2016 年(或其中的一部分)期间,1 型糖尿病患者的年龄和性别标准化全因死亡率下降,死亡率的年变化率范围为-2.1%(95%CI-2.8%,-1.3%)至-5.8%(95%CI-6.5%,-5.1%)。男性和年龄较大的个体全因死亡率较高,但死亡率的下降速度一般不受性别或年龄的影响。女性个体的 SMR 高于男性个体,且似乎在 40-70 岁时达到峰值。丹麦、苏格兰和西班牙的 SMR 随时间下降,而其他三个数据源则保持稳定。
结论/解释:近年来,大多数纳入人群中 1 型糖尿病患者的全因死亡率有所下降,但与非糖尿病患者相比,死亡率的改善情况并不一致。